Further, we investigated the effects of cerivastatin on targeting the GFP-K-Ras protein trafficking, as well as the regulation of invasiveness of pancreatic adenocarcinoma cells in vitro, elucidating the potential involvement of statins in pancreatic cancer therapy. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.